Cargando…

2106. Evaluation of Isavuconazole for the Prophylaxis and Treatment of Invasive Fungal Infections at a Large Academic Medical Center

BACKGROUND: Isavuconazole is an azole antifungal with in vitro activity against various fungi, including Candida spp, Aspergillus, and Mucormycetes. Currently, isavuconazole is FDA approved for the treatment of invasive aspergillosis and mucormycosis; however, there remains limited data to support p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vu, Christine, Rana, Meenakshi, Saunders-Hao, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809438/ http://dx.doi.org/10.1093/ofid/ofz360.1786

Ejemplares similares

Economic Outcomes of Isavuconazole to Prevent Invasive Fungal Infection in Immunocompromised Adults: Initial Experience at an Academic Medical Center
por: Kowalewska, Christina A, et al.
Publicado: (2017)

Real-World Use – Isavuconazole at a Large Academic Medical Center
por: Hassouna, HabiBA, et al.
Publicado: (2017)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

1726. Patterns of Isavuconazole Use for Invasive Fungal Infections
por: Gow-Lee, Vanessa, et al.
Publicado: (2022)

819. Experience with Isavuconazole Use for Treatment of Invasive Fungal Infections
por: Gow-Lee, Vanessa, et al.
Publicado: (2023)

941. Isavuconazole Prophylaxis Against Invasive Fungal Infection: A Pooled Analysis with a Comparison of Posaconazole Delayed-release Tablet Prophylaxis
por: Lee, Chaeryoung, et al.
Publicado: (2021)

Isavuconazole for invasive fungal infections
Publicado: (2020)

360. Breakthrough Invasive Pulmonary Aspergillosis During Isavuconazole Prophylaxis in Patients with Hematologic Malignancies: A Single-Center Experience
por: Fontana, Lauren, et al.
Publicado: (2018)

Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience
por: Salas, Maria Queralt, et al.
Publicado: (2022)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

Role of isavuconazole in the treatment of invasive fungal infections
por: Wilson, Dustin T, et al.
Publicado: (2016)

2709. Breakthrough fungal infection after isavuconazole primary prophylaxis in patients with hematologic malignancy and hematopoietic stem cell transplant: Systematic Review
por: Ishida, Keiko, et al.
Publicado: (2023)

2106. What Metrics Should We Use to Evaluate CAUTI Performance for Inpatient Rehabilitation Units? An Evaluation of a Large, National Healthcare System
por: Sharma, Mamta, et al.
Publicado: (2018)

Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients
por: Zimmermann, Philippe, et al.
Publicado: (2022)

2110. Treatment of Coccidioidomycosis with Isavuconazole
por: Jamros, Christina, et al.
Publicado: (2019)

Clinical research advances of isavuconazole in the treatment of invasive fungal diseases
por: Zhang, Tingting, et al.
Publicado: (2022)

2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study
por: Bose, Prithviraj, et al.
Publicado: (2019)

1702. Assessing the Safety and Efficacy of Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipients on Hemodialysis
por: Yee, Jason, et al.
Publicado: (2020)

PReS-FINAL-2106: Clinical psoriatic arthritis of specific children
por: Chebisheva, S, et al.
Publicado: (2013)

Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections
por: Falci, Diego R, et al.
Publicado: (2013)

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
por: Zurl, Christoph, et al.
Publicado: (2020)

Measles Cases during Ebola Outbreak, West Africa, 2013–2106
por: Colavita, Francesca, et al.
Publicado: (2017)

393. Isavuconazole in the Treatment of Coccidioidal Meningitis
por: Heidari, Arash, et al.
Publicado: (2018)

1291. Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
por: Bogler, Yael, et al.
Publicado: (2020)

Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system
por: Schwartz, Stefan, et al.
Publicado: (2020)

2106. Desirability of Outcome Ranking (DOOR): Application to a Phase 3 Registrational Trial Evaluating Sulopenem for Patients with Complicated Intra-abdominal Infection (cIAI)
por: Aronin, Steven I, et al.
Publicado: (2023)

2537. Population Pharmacokinetics of Isavuconazole in Pediatric Patients
por: Desai, Amit, et al.
Publicado: (2023)

837. Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis
por: Heidari, Arash, et al.
Publicado: (2023)

Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients
por: Bellanger, Anne-Pauline, et al.
Publicado: (2019)

1064. Antimicrobial Stewardship Program at a Large Academic Medical Center, Impact Over 12 Years
por: Kline, Susan E, et al.
Publicado: (2019)

Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus
por: Al-Obaidi, Mohanad, et al.
Publicado: (2018)

1182. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: dagher, Hiba, et al.
Publicado: (2020)

2446. Effect of the Implementation of a Fluconazole Prophylaxis Protocol on the Incidence of Invasive Fungal Infection in High-Risk Neonates
por: Isada, Patricia Marie D, et al.
Publicado: (2023)

Therapeutic efficacy of isavuconazole in experimental Aspergillus fumigatus endophthalmitis
por: Guest, John, et al.
Publicado: (2017)

Real-World, Multicenter Case Series of Patients Treated with Isavuconazole for Invasive Fungal Disease in China
por: Wu, Lisha, et al.
Publicado: (2023)

An Increase in Invasive Infections due to Corynebacterium striatum at an Academic Medical Center
por: Smith, Becky, et al.
Publicado: (2017)

476. Epidemiology and Outcomes of Candidemia in a Large Academic Medical Center
por: Pek, Zachary, et al.
Publicado: (2022)

358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)
por: Cheng, Matthew P, et al.
Publicado: (2018)

610. Voriconazole versus isavuconazole in patients with invasive aspergillosis: a retrospective study in a medically insured population across the United States
por: Chan, Sophea, et al.
Publicado: (2023)

411. Tolerability of Isavuconazole After Posaconazole Toxicity in Leukemia Patients
por: DiPippo, Adam J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3j1eq0ce7403lh3tirasnhqnri